Antares signs licensing deal with Daewoong for Oxybutynin Gel 3%
Antares oxybutynin gel 3% is a topical, translucent hydroalcoholic gel containing oxybutynin, an antispasmodic, antimuscarinic agent and is indicated for the treatment of (OAB). The FDA approved oxybutynin
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.